Home > Request Information
Title:
APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh